Last reviewed · How we verify
CAR T cells chimeric antigen receptor cells — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
CAR T cells chimeric antigen receptor cells (CAR T cells chimeric antigen receptor cells) — Institute of Hematology & Blood Diseases Hospital, China.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| CAR T cells chimeric antigen receptor cells TARGET | CAR T cells chimeric antigen receptor cells | Institute of Hematology & Blood Diseases Hospital, China | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- CAR T cells chimeric antigen receptor cells CI watch — RSS
- CAR T cells chimeric antigen receptor cells CI watch — Atom
- CAR T cells chimeric antigen receptor cells CI watch — JSON
- CAR T cells chimeric antigen receptor cells alone — RSS
Cite this brief
Drug Landscape (2026). CAR T cells chimeric antigen receptor cells — Competitive Intelligence Brief. https://druglandscape.com/ci/car-t-cells-chimeric-antigen-receptor-cells. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab